Myles Minter
Stock Analyst at William Blair
(4.91)
# 248
Out of 5,023 analysts
612
Total ratings
51.5%
Success rate
27.2%
Average return
Main Sectors:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience | Reiterated: Buy | n/a | $24.80 | - | 15 | Oct 2, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | n/a | $13.12 | - | 12 | Sep 30, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | n/a | $4.00 | - | 13 | Sep 29, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | n/a | $13.03 | - | 23 | Sep 24, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | n/a | $32.17 | - | 4 | Sep 23, 2026 | |
| VTGN Vistagen Therapeutics | Reiterated: Hold | n/a | $0.281 | - | 14 | Sep 23, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | n/a | $43.54 | - | 55 | Sep 22, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | n/a | $504.73 | - | 35 | Sep 22, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | n/a | $88.21 | - | 22 | Sep 18, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | n/a | $38.02 | - | 16 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.96 | - | 15 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.64 | - | 27 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.87 | - | 14 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $190.01 | - | 30 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.4999 | - | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.38 | - | 11 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $67.25 | - | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $179.25 | - | 64 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.81 | - | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.00 | - | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.64 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.26 | - | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.96 | - | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.38 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $143.18 | - | 32 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $219.72 | - | 17 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $219.88 | - | 31 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $919.21 | - | 19 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.01 | - | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.56 | n/a | 3 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.47 | n/a | 3 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $295.51 | n/a | 5 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.28 | n/a | 15 | Dec 29, 2022 |
Alto Neuroscience
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.80
Upside: -
Contineum Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.12
Upside: -
Camp4 Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.00
Upside: -
Arcturus Therapeutics Holdings
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.03
Upside: -
Rapport Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.17
Upside: -
Vistagen Therapeutics
Sep 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.281
Upside: -
Ionis Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $43.54
Upside: -
Vertex Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $504.73
Upside: -
Dianthus Therapeutics
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $88.21
Upside: -
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $38.02
Upside: -
Sep 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.96
Upside: -
Sep 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.64
Upside: -
Sep 9, 2026
Rated: Hold
Price Target: n/a
Current: $12.87
Upside: -
Aug 19, 2026
Upgraded: Buy
Price Target: n/a
Current: $190.01
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.4999
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.38
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $67.25
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $179.25
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.81
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.00
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.64
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.26
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.96
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.38
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $143.18
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $219.72
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $219.88
Upside: -
Jun 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $919.21
Upside: -
Mar 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.01
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $2.56
Upside: n/a
Sep 28, 2023
Reiterated: Buy
Price Target: n/a
Current: $3.47
Upside: n/a
Mar 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $295.51
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $3.28
Upside: n/a